M. D. Mullican, M. W. Wilson, D. T. Connor, C. R. Kostlan, D. J. Schrier and R. D. Dyer, “Design of 5-(3,5- Di-tert-butyl-4-hydroxyl-phenyl)-1,3,4-thiadiazoles, -1,3,4- Oxadiazoles, and -1,2,4-Triazoles as Orally-Active, Nonulcerogenic Antiinflammatory Agents,” Journal of Medicinal Chemistry, Vol. 36, No. 8, 1993, pp. 1090-1099. doi:10.1021/jm00060a017

has been cited by the following article:

• TITLE: The Reaction of Cyanoacetylhdrazine with Furan-2-Aldehyde: Novel Synthesis of Thiophene, Azole, Azine and Coumarin Derivatives and Their Antitumor Evaluation

  AUTHORS: Wagnat W. Wardakhan, Sherif M. Sherif, Rafat M. Mohareb, Amr S. Abouzied

  KEYWORDS: Acetylhydrazine; Hydrazide-Hydrazone; Thiophene; Thiazole; Pyridine; Coumarin; Antitumor

  JOURNAL NAME: International Journal of Organic Chemistry, Vol.2 No.4, December 27, 2012

  ABSTRACT: The reaction of cyanoacetylhydrazine 1 with furan-2-aldehyde 2 gives the hydrazide-hydrazone derivative 3. The latter compound undergoes a series of heterocyclization reactions to give new heterocyclic compounds. The antitumor evaluation of the newly synthesized products against three cancer cell lines, namely breast adenocarcinoma (MCF-7), non-small cell lung cancer (NCI-H460) and CNS cancer (SF-268) were recorded. Some of the synthesized compounds show high inhibitory effects.